Strategies to Improve the Safety and Efficacy of Biparatopic Antibody Drug Conjugates

被引：0

作者：

Comer, Frank, I ^{[1
]}

Wang, Xinzhong ^{[2
]}

Yuan, Andy Q. ^{[3
]}

Muniz-Medina, Vanessa ^{[1
]}

Sadowska, Agnieszka ^{[1
]}

Xu, Lan ^{[1
]}

Perry, Samuel ^{[4
]}

Thompson, Pamela ^{[5
]}

Minter, Ralph ^{[6
]}

Woods, Robert ^{[1
]}

Hinrichs, Mary Jane ^{[1
]}

Reed, Molly ^{[1
]}

Affif-Rider, Shameen ^{[1
]}

Rebelatto, Marlon ^{[1
]}

Brown, Charles ^{[1
]}

Feng, Hui ^{[7
]}

Dixit, Rakesh ^{[1
]}

Coats, Steven ^{[1
]}

Osbourn, Jane ^{[1
]}

机构：

[1] Medimmune, Gaithersburg, MD USA

[2] CStone Pharmaceut, Shanghai, Peoples R China

[3] Excyte LLC, Rockville, MD USA

[4] Compass Therapeut, Cambridge, MA USA

[5] AbbVie, Chicago, IL USA

[6] Medimmune, Cambridge, England

[7] Topalliance Biosci, Rockville, MD USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期

关键词：

D O I：

10.1158/1535-7163.TARG-17-LB-A20

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-A20

引用

页数：2

共 50 条

[1] Antibody drug conjugates: Design considerations for improving efficacy and safety
Trail, Pamela
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[2] Advances in Linker Technology: Improving the Safety and Efficacy of Antibody Drug Conjugates
Challener, Cynthia A.
BIOPHARM INTERNATIONAL, 2014, 27 (03) : 22 - +
[3] Protein labeling approach to improve lysosomal targeting and efficacy of antibody-drug conjugates
Han, Ying
Da, Yifan
Yu, Mingjia
Cheng, Yaping
Wang, Xin
Xiong, Jiale
Guo, Guoying
Li, Yan
Jiang, Xianxing
Cai, Xiaoqing
ORGANIC & BIOMOLECULAR CHEMISTRY, 2020, 18 (17) : 3229 - 3233
[4] Antibody Drug Conjugates: Nonclinical Safety Considerations
Mary Jane Masson Hinrichs
Rakesh Dixit
The AAPS Journal, 2015, 17 : 1055 - 1064
[5] In vivo safety testing of Antibody Drug Conjugates
Pretto, Francesca
FitzGerald, Rex E.
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2021, 122
[6] SAFETY ASSESSMENT CONSIDERATIONS FOR ANTIBODY DRUG CONJUGATES
Hinkle, Beth
DRUG METABOLISM REVIEWS, 2012, 44 : 23 - 24
[7] The safety of antibody drug conjugates: A literature review
Forns, Joan
Kaye, James A.
Lievano, Fabio A.
Tyczynski, Jerzy E.
Margulis, Andrea V.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 567 - 567
[8] Antibody Drug Conjugates: Nonclinical Safety Considerations
Hinrichs, Mary Jane Masson
Dixit, Rakesh
AAPS JOURNAL, 2015, 17 (05): : 1055 - 1064
[9] Antibody engineering for improving efficacy of antibody-drug conjugates
Tsumura, Ryo
Anzai, Takahiro
Takashima, Hiroki
Koga, Yoshikatsu
Yasunaga, Masahiro
CANCER SCIENCE, 2022, 113 : 1700 - 1700
[10] Engineering hydrophobicity and manufacturability for optimized biparatopic antibody-drug conjugates targeting c-MET
Evers, Andreas
Krah, Simon
Demir, Deniz
Gaa, Ramona
Elter, Desislava
Schroeter, Christian
Zielonka, Stefan
Rasche, Nicolas
Dotterweich, Julia
Knuehl, Christine
Doerner, Achim
MABS, 2024, 16 (01)

← 1 2 3 4 5 →